Sep 29, 2017 13:15 pm UTC| Business
SAINT-GENIS-POUILLY, France, Sept. 29, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that the...
CDLU Calls on Trump Administration to Fire Acting U.S. Assistant Attorney General Jeffrey H. Wood
Sep 29, 2017 13:15 pm UTC| Business
WASHINGTON, Sept. 29, 2017 -- With the federal indictment yesterday of two partners of the embattled law firm Balch Bingham, the Consejo de Latinos Unidos (CDLU), a national advocacy group and public charity, called on...
Sep 29, 2017 13:10 pm UTC| Business
Herndon, VA, Sept. 29, 2017 -- According to a recent report, Deltek forecasts federal IT spending of $99.5B in FY 2017, increasing to $104.9B by FY 2022. While key technology and acquisition leadership positions remain...
Wabash National Corporation Announces New Group Presidents
Sep 29, 2017 13:00 pm UTC| Business
LAFAYETTE, Ind., Sept. 29, 2017 -- Wabash National Corporation (NYSE:WNC), a diversified industrial manufacturer and North America’s leading producer of semi-trailers and liquid transportation systems, today announced...
Sep 29, 2017 13:00 pm UTC| Business
LAKEWOOD, N.J., Sept. 29, 2017 -- Reflecting its commitment to build on the proven strength of its literacy platform for PreK – 12 and Adult Education, Achieve3000® today announced an innovative partnership with...
LifeVantage Holds its 2nd Annual Canada Leadership Academy
Sep 29, 2017 13:00 pm UTC| Business
SALT LAKE CITY, Sept. 29, 2017 -- LifeVantage Corporation (Nasdaq:LFVN) held its second annual Canada Leadership Academy earlier this month in Vancouver, BC. More than 450 people attended the highly anticipated...
INSYS Therapeutics Files New Drug Application (NDA) for Buprenorphine Sublingual Spray with FDA
Sep 29, 2017 13:00 pm UTC| Business
PHOENIX, Sept. 29, 2017 -- In advancing its pipeline of innovative medicines, INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), announced today that it filed a New Drug Application (NDA) for a novel...